GeoVax Labs (GOVX) had the highest return in 1995 by a US stock in the Biotechnology Industry, returning 1,087.5%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GeoVax Labs (GOVX) | 1995 | 1,087.5% |
Biogen (BIIB) | 1995 | 791.39% |
Capstone Holding Corp Common Stock (CAPS) | 1995 | 300% |
Regeneron Pharmaceuticals (REGN) | 1995 | 277.78% |
Alkermes (ALKS) | 1995 | 273.53% |
Gilead Sciences (GILD) | 1995 | 236.95% |
Ionis Pharmaceuticals (IONS) | 1995 | 228.13% |
Arrowhead Pharmaceuticals (ARWR) | 1995 | 166.67% |
ImmuCell (ICCC) | 1995 | 116.67% |
Anika Therapeutics (ANIK) | 1995 | 106.67% |
Amgen (AMGN) | 1995 | 101.7% |
BioCryst Pharmaceuticals (BCRX) | 1995 | 89.74% |
Incyte (INCY) | 1995 | 83.48% |
Abeona Therapeutics (ABEO) | 1995 | 78.95% |
Lineage Cell Therapeutics (LCTX) | 1995 | 78.57% |
Achieve Life Sciences (ACHV) | 1995 | 78.18% |
Vertex Pharmaceuticals (VRTX) | 1995 | 76.67% |
Anixa Biosciences (ANIX) | 1995 | 52.48% |
Myriad Genetics (MYGN) | 1995 | 51.74% |
Amarin (AMRN) | 1995 | 38.46% |
Ligand Pharmaceuticals (LGND) | 1995 | 30.3% |
Compass Therapeutics (CMPX) | 1995 | 26.09% |
Heron Therapeuti (HRTX) | 1995 | 25.71% |
XOMA (XOMA) | 1995 | 24.45% |
Celldex Therapeutics (CLDX) | 1995 | 19.05% |
